Meta Pixel

News and Announcements

Digital Health and Wellbeing Platform with 50K NHS patients | Selected for Microsoft Startups Programme 2021

  • Published July 29, 2021 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

“Nexus is creating a global movement in the health and wellness space. Our approach is inclusive, and we empower our users to change the way they think about their wellbeing on a bespoke basis.

We have shifted from treating people once they fall sick to providing a personalised, proactive, and prevention-based digital platform that enables users to take control of their wellbeing and
live a healthy, happy lifestyle.”

Mona Hayat, Founder & CEONexus Digital Technology

Register Interest

Executive Summary

Nexus is a digital platform that educates and empowers users to take control of their health and wellbeing. Through the Nexus app and web-based platform, the company digitally connects users with health and wellbeing coaches, telemental health support, lifestyle activities, educational tools, and valuable resources that enable them to make informed decisions.

The platform tracks users’ progress by aggregating data and information (via wearables) to inspire lifelong behaviour change.

Nexus is not a clinical platform, nor does it seek to disrupt the medical sector. It significantly complements medical services by focusing on proactive initiatives and early intervention that ultimately benefits its users.

Investment Highlights

  • Nexus secured a 5-year contract with Guys and St Thomas’ NHS Foundation Trust, a leading London hospital for digital innovation. The contract includes the rollout of the platform to 50,000 prostate cancer patients nationally in the UK.
  • Nexus was selected to be a part of the Microsoft for Startups Programme in 2021 and
    was named one of the “Top 100 Startups” by the World Business Angels Forum in
    2020.
  • In 2019, Nexus’ CEO received the “Top Global Leader in Healthcare” award from the      US Institute of Advancements in Healthcare.
  • The Royal Family Office of Bahrain has endorsed the company. Nexus’ CEO is also the
    Healthcare Advisor to the Royal Family Office of Sheikh Abdul Aziz.
  • Nexus has recruited a senior leadership team based across the UK and Dubai. The team
    consists of healthcare, technology, and behaviour science experts and includes physical
    and mental health clinicians.
  • Nexus has developed a revenue-generating health and wellbeing coaching programme that provides coaching via the Nexus app.
  • Nexus has partnered with the University of Health & Research in Dubai and the University of London. These universities are developing Nexus’ research programme.

Investment Offering

Nexus is seeking £1M to deliver phase 2 of its technology build and grow its marketing, business development, and customer support teams.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now